Scientists from the Department of Geography and Environmental Science at Queen Mary University of London have developed a ...
Procyon is a new cancer diagnostics spinout from Queen Mary University of London which has just completed an oversubscribed ...
Announced at the House of Lords, findings from the paper in The Lancet: Healthy Longevity demonstrate that the intervention, ...
The pioneering study uses a new approach to detect the presence of circulating tumour DNA (ctDNA) to accurately identify ...
“Our findings highlight menopause as a critical turning point for women’s immunity. While ageing affects everyone, the loss ...
A podcast that uncovers London’s hidden Cockney Yiddish culture, hosted by Queen Mary historians Professor Nadia Valman and ...
Dr Rageshri Dhairyawan has been awarded the Gilead & Kite Campaigner for Health Equity Award at the 2025 Women of the Year ...
Queen Mary University of London and Barking and Dagenham Council have launched a major new partnership to tackle local health ...
Rapalink-1, the new drug studied by the team, is a next-generation TOR inhibitor currently under investigation for cancer therapy. The researchers found that rapalink-1 not only slowed aspects of ...
Queen Mary University of London has partnered with the MassChallenge startup accelerator to offer a new route to impact for ...
The latest Research.com rankings have named four Queen Mary researchers among the top 100 scientists in the UK, recognising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback